or Try an Advanced Search...

    Technical Analysis for BDSX - Biodesix, Inc.

    Grade Last Price % Change Price Change
    D 1.45 -6.45% -0.10
    BDSX closed unchanged on Wednesday, May 8, 2024, on 47 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical BDSX trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish -6.45%
    Upper Bollinger Band Walk Strength -6.45%
    Earnings Movers Other -6.45%
    Wide Bands Range Expansion -6.45%
    Above Upper BB Strength -6.45%
    Overbought Stochastic Strength -6.45%
    Upper Bollinger Band Touch Strength -6.45%
    Gapped Down Weakness -6.45%
    200 DMA Resistance Bearish -6.45%
    50 DMA Support Bullish -6.45%
    Older End-of-Day Signals for BDSX ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 28 minutes ago
    Down 1 ATR 28 minutes ago
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    Down 3% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BDSX Chart by TradingView
    Basic chart:

    Profile

    Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests provide physicians with timely results to facilitate treatment decisions. It also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated 2005 and is headquartered in Boulder, Colorado.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biopharmaceutical Clinical Research Lung Cancer Companion Diagnostic Diagnostic Solutions

    Is BDSX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Biodesix GAAP EPS of -$0.14, revenue of $14.8M
    May 8 Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
    May 8 Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
    May 7 Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
    Apr 24 Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
    Apr 13 The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX)
    Apr 9 Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
    Apr 5 Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March
    Apr 5 Biodesix prices its 17.4M shares offering at $1.15 apiece
    Apr 5 Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
    See more BDSX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.21
    52 Week Low 1.03
    Average Volume 154,541
    200-Day Moving Average 1.55
    50-Day Moving Average 1.39
    20-Day Moving Average 1.30
    10-Day Moving Average 1.35
    Average True Range 0.09
    RSI (14) 69.51
    ADX 24.81
    +DI 29.66
    -DI 15.77
    Chandelier Exit (Long, 3 ATRs) 1.31
    Chandelier Exit (Short, 3 ATRs) 1.41
    Upper Bollinger Bands 1.52
    Lower Bollinger Band 1.09
    Percent B (%b) 1.08
    BandWidth 32.97
    MACD Line 0.02
    MACD Signal Line -0.02
    MACD Histogram 0.0448
    Fundamentals Value
    Market Cap 140.24 Million
    Num Shares 90.5 Million
    EPS -0.88
    Price-to-Earnings (P/E) Ratio -1.76
    Price-to-Sales 3.19
    Price-to-Book 6.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.66
    Resistance 3 (R3) 1.65 1.61 1.64
    Resistance 2 (R2) 1.61 1.58 1.61 1.63
    Resistance 1 (R1) 1.58 1.57 1.60 1.59 1.63
    Pivot Point 1.54 1.54 1.55 1.54 1.54
    Support 1 (S1) 1.51 1.51 1.53 1.52 1.47
    Support 2 (S2) 1.47 1.50 1.47 1.47
    Support 3 (S3) 1.44 1.47 1.46
    Support 4 (S4) 1.45